Base to Base Biotech

Base to Base Biotech

Jim Cornall

60 - Base to Base biotech podcast 60: Delivery method reduces prostate cancer tumour size

The Base to Base Biotech podcast is a weekly look at what's happening in the world of biotech, with interviews with biotech leaders around the world.

Whether it's a new drug, cutting-edge technology, product launches, new technology, major finding announcement or clinical trial results, Base to Base Biotech keeps you informed.

The podcast is hosted by former biotech editor and broadcaster, the award-winning media veteran Jim Cornall.

Base to Base is an Ayr Coastal Media Ltd production.

60 - Base to Base biotech podcast 60: Delivery method reduces prostate cancer tumour size
00:00
00:00

The Base to Base Biotech podcast is a weekly look at what's happening in the world of biotech, with interviews with biotech leaders around the world.

Whether it's a new drug, cutting-edge technology, product launches, new technology, major finding announcement or clinical trial results, Base to Base Biotech keeps you informed.

The podcast is hosted by former biotech editor and broadcaster, the award-winning media veteran Jim Cornall.

Base to Base is an Ayr Coastal Media Ltd production.

Afleveringen

60-

Base to Base biotech podcast 60: Delivery method reduces prostate cancer tumour size

vr, 22 mei 2026
59-

Base to Base biotech podcast 59: DIA helping biotech thrive, and Gorlin syndrome

vr, 15 mei 2026
58-

Base to Base biotech podcast 58: Congenital myotonic dystrophy

vr, 08 mei 2026
57-

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

vr, 01 mei 2026
56-

Base to Base biotech podcast 56: GRIN genes and relapsing MS

vr, 24 apr. 2026